{"pmid":32451533,"title":"Molecular Detection of SARS-CoV-2 Infection in FFPE Samples and Histopathologic Findings in Fatal SARS-CoV-2 Cases.","text":["Molecular Detection of SARS-CoV-2 Infection in FFPE Samples and Histopathologic Findings in Fatal SARS-CoV-2 Cases.","OBJECTIVES: To report methods and findings of 2 autopsies with molecular evaluation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive individuals. METHODS: Postmortem examination was completed following Centers for Disease Control and Prevention public guidelines. Numerous formalin-fixed paraffin-embedded (FFPE) tissue types from each case were surveyed for SARS-CoV-2 RNA by quantitative reverse transcription polymerase chain reaction (qRT-PCR). SARS-CoV-2 viral genome was sequenced by next-generation sequencing (NGS) from FFPE lung tissue blocks. RESULTS: Postmortem examinations revealed diffuse alveolar damage, while no viral-associated hepatic, cardiac, or renal damage was observed. Viral RNA was detected in lungs, bronchi, lymph nodes, and spleen in both cases using qRT-PCR method. RNA sequencing using NGS in case 1 revealed mutations most consistent with Western European Clade A2a with ORF1a L3606F mutation. CONCLUSIONS: SARS-CoV-2 testing and viral sequencing can be performed from FFPE tissue. Detection and sequencing of SARS-CoV-2 in combination with morphological findings from postmortem tissue examination can aid in gaining a better understanding of the virus's pathophysiologic effects on human health.","Am J Clin Pathol","Sekulic, Miroslav","Harper, Holly","Nezami, Behtash G","Shen, Daniel L","Sekulic, Simona Pichler","Koeth, Aaron T","Harding, Clifford V","Gilmore, Hannah","Sadri, Navid","32451533"],"abstract":["OBJECTIVES: To report methods and findings of 2 autopsies with molecular evaluation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive individuals. METHODS: Postmortem examination was completed following Centers for Disease Control and Prevention public guidelines. Numerous formalin-fixed paraffin-embedded (FFPE) tissue types from each case were surveyed for SARS-CoV-2 RNA by quantitative reverse transcription polymerase chain reaction (qRT-PCR). SARS-CoV-2 viral genome was sequenced by next-generation sequencing (NGS) from FFPE lung tissue blocks. RESULTS: Postmortem examinations revealed diffuse alveolar damage, while no viral-associated hepatic, cardiac, or renal damage was observed. Viral RNA was detected in lungs, bronchi, lymph nodes, and spleen in both cases using qRT-PCR method. RNA sequencing using NGS in case 1 revealed mutations most consistent with Western European Clade A2a with ORF1a L3606F mutation. CONCLUSIONS: SARS-CoV-2 testing and viral sequencing can be performed from FFPE tissue. Detection and sequencing of SARS-CoV-2 in combination with morphological findings from postmortem tissue examination can aid in gaining a better understanding of the virus's pathophysiologic effects on human health."],"journal":"Am J Clin Pathol","authors":["Sekulic, Miroslav","Harper, Holly","Nezami, Behtash G","Shen, Daniel L","Sekulic, Simona Pichler","Koeth, Aaron T","Harding, Clifford V","Gilmore, Hannah","Sadri, Navid"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32451533","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1093/ajcp/aqaa091","keywords":["autopsy","covid-19","ffpe","molecular testing","sars-cov-2; coronavirus","viral sequencing","ncov-19"],"locations":["bronchi"],"e_drugs":["Paraffin","Formaldehyde"],"topics":["Mechanism","Diagnosis"],"weight":1,"_version_":1667881798526304256,"score":9.490897,"similar":[{"pmid":32379723,"title":"Molecular detection of SARS-CoV-2 in formalin fixed paraffin embedded specimens.","text":["Molecular detection of SARS-CoV-2 in formalin fixed paraffin embedded specimens.","Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of human coronavirus disease 2019 (COVID-19), emerged in Wuhan, China in December 2019. The virus rapidly spread globally, resulting in a public-health crisis including more than 3.1 million cases and 224,000 deaths as of May 1, 2020. Here, we describe the identification and evaluation of commercially available reagents and assays for the molecular detection of SARS-CoV-2 in infected formalin fixed paraffin embedded (FFPE) cell pellets. We identified a suitable rabbit polyclonal anti-SARS-CoV spike protein antibody and a mouse monoclonal anti-SARS-CoV nucleocapsid protein (NP) antibody for cross detection of the respective SARS-CoV-2 proteins by immunohistochemistry (IHC) and immunofluorescence assay (IFA). Next, we established RNAscope in situ hybridization (ISH) to detect SARS-CoV-2 RNA. Furthermore, we established a multiplex fluorescence ISH (mFISH) to detect positive-sense SARS-CoV-2 RNA and negative-sense SARS-CoV-2 RNA (a replicative intermediate indicating viral replication). Finally, we developed a dual staining assay using IHC and ISH to detect SARS-CoV-2 antigen and RNA in the same FFPE section. These reagents and assays will accelerate COVID-19 pathogenesis studies in humans and in COVID-19 animal models.","JCI Insight","Liu, Jun","Babka, April M","Kearney, Brian J","Radoshitzky, Sheli R","Kuhn, Jens H","Zeng, Xiankun","32379723"],"abstract":["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of human coronavirus disease 2019 (COVID-19), emerged in Wuhan, China in December 2019. The virus rapidly spread globally, resulting in a public-health crisis including more than 3.1 million cases and 224,000 deaths as of May 1, 2020. Here, we describe the identification and evaluation of commercially available reagents and assays for the molecular detection of SARS-CoV-2 in infected formalin fixed paraffin embedded (FFPE) cell pellets. We identified a suitable rabbit polyclonal anti-SARS-CoV spike protein antibody and a mouse monoclonal anti-SARS-CoV nucleocapsid protein (NP) antibody for cross detection of the respective SARS-CoV-2 proteins by immunohistochemistry (IHC) and immunofluorescence assay (IFA). Next, we established RNAscope in situ hybridization (ISH) to detect SARS-CoV-2 RNA. Furthermore, we established a multiplex fluorescence ISH (mFISH) to detect positive-sense SARS-CoV-2 RNA and negative-sense SARS-CoV-2 RNA (a replicative intermediate indicating viral replication). Finally, we developed a dual staining assay using IHC and ISH to detect SARS-CoV-2 antigen and RNA in the same FFPE section. These reagents and assays will accelerate COVID-19 pathogenesis studies in humans and in COVID-19 animal models."],"journal":"JCI Insight","authors":["Liu, Jun","Babka, April M","Kearney, Brian J","Radoshitzky, Sheli R","Kuhn, Jens H","Zeng, Xiankun"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32379723","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1172/jci.insight.139042","keywords":["covid-19","molecular diagnosis","molecular pathology","virology"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Paraffin","Formaldehyde"],"topics":["Diagnosis"],"weight":1,"_version_":1666597097288237056,"score":327.06},{"pmid":32275742,"pmcid":"PMC7184436","title":"COVID-19 Autopsies, Oklahoma, USA.","text":["COVID-19 Autopsies, Oklahoma, USA.","OBJECTIVES: To report the methods and findings of two complete autopsies of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive individuals who died in Oklahoma (United States) in March 2020. METHODS: Complete postmortem examinations were performed according to standard procedures in a negative-pressure autopsy suite/isolation room using personal protective equipment, including N95 masks, eye protection, and gowns. The diagnosis of coronavirus disease 2019 (COVID-19) was confirmed by real-time reverse transcriptase polymerase chain reaction testing on postmortem swabs. RESULTS: A 77-year-old obese man with a history of hypertension, splenectomy, and 6 days of fever and chills died while being transported for medical care. He tested positive for SARS-CoV-2 on postmortem nasopharyngeal and lung parenchymal swabs. Autopsy revealed diffuse alveolar damage and chronic inflammation and edema in the bronchial mucosa. A 42-year-old obese man with a history of myotonic dystrophy developed abdominal pain followed by fever, shortness of breath, and cough. Postmortem nasopharyngeal swab was positive for SARS-CoV-2; lung parenchymal swabs were negative. Autopsy showed acute bronchopneumonia with evidence of aspiration. Neither autopsy revealed viral inclusions, mucus plugging in airways, eosinophils, or myocarditis. CONCLUSIONS: SARS-CoV-2 testing can be performed at autopsy. Autopsy findings such as diffuse alveolar damage and airway inflammation reflect true virus-related pathology; other findings represent superimposed or unrelated processes.","Am J Clin Pathol","Barton, Lisa M","Duval, Eric J","Stroberg, Edana","Ghosh, Subha","Mukhopadhyay, Sanjay","32275742"],"abstract":["OBJECTIVES: To report the methods and findings of two complete autopsies of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive individuals who died in Oklahoma (United States) in March 2020. METHODS: Complete postmortem examinations were performed according to standard procedures in a negative-pressure autopsy suite/isolation room using personal protective equipment, including N95 masks, eye protection, and gowns. The diagnosis of coronavirus disease 2019 (COVID-19) was confirmed by real-time reverse transcriptase polymerase chain reaction testing on postmortem swabs. RESULTS: A 77-year-old obese man with a history of hypertension, splenectomy, and 6 days of fever and chills died while being transported for medical care. He tested positive for SARS-CoV-2 on postmortem nasopharyngeal and lung parenchymal swabs. Autopsy revealed diffuse alveolar damage and chronic inflammation and edema in the bronchial mucosa. A 42-year-old obese man with a history of myotonic dystrophy developed abdominal pain followed by fever, shortness of breath, and cough. Postmortem nasopharyngeal swab was positive for SARS-CoV-2; lung parenchymal swabs were negative. Autopsy showed acute bronchopneumonia with evidence of aspiration. Neither autopsy revealed viral inclusions, mucus plugging in airways, eosinophils, or myocarditis. CONCLUSIONS: SARS-CoV-2 testing can be performed at autopsy. Autopsy findings such as diffuse alveolar damage and airway inflammation reflect true virus-related pathology; other findings represent superimposed or unrelated processes."],"journal":"Am J Clin Pathol","authors":["Barton, Lisa M","Duval, Eric J","Stroberg, Edana","Ghosh, Subha","Mukhopadhyay, Sanjay"],"date":"2020-04-11T11:00:00Z","year":2020,"_id":"32275742","source":"PubMed","week":"202015|Apr 06 - Apr 12","doi":"10.1093/ajcp/aqaa062","keywords":["acute lung injury","autopsy","covid-19","coronavirus","diffuse alveolar damage","pulmonary pathology","sars-cov-2"],"locations":["Oklahoma","United States","obese","obese","Oklahoma","USA"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Case Report"],"weight":1,"_version_":1666138491676786692,"score":315.45386},{"pmid":32469258,"title":"Detection of SARS-CoV-2 in Human Retinal Biopsies of Deceased COVID-19 Patients.","text":["Detection of SARS-CoV-2 in Human Retinal Biopsies of Deceased COVID-19 Patients.","PURPOSE: To report the presence of viral ribonucleic acid (RNA) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human retina in deceased patients with confirmed novel coronavirus disease 2019 (COVID-19). PATIENTS AND METHODS: Fourteen eyes of 14 deceased patients with confirmed COVID-19 disease were enucleated during autopsy. A sample of human retina was secured and fixed in RNAlater. Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) was performed to detect three different viral RNA sequences (RdRp-gene, E-gene and Orf1 gene) of SARS-CoV-2. RESULTS: In three out of 14 eyes SARS-CoV-2 viral RNA was detected in the retina of deceased COVID-19 patients. As analysis for three different sequences (RdRp-gene, E-gene and Orf1 gene) revealed positive results in RT-PCR, the existence of SARS-CoV-2 viral RNA in human retina is proven according to the standards of the World-Health-Organization. CONCLUSION: Viral RNA of SARS-CoV-2 is detectable in the retina of COVID-19 patients.","Ocul Immunol Inflamm","Casagrande, Maria","Fitzek, Antonia","Puschel, Klaus","Aleshcheva, Ganna","Schultheiss, Heinz-Peter","Berneking, Laura","Spitzer, Martin S","Schultheiss, Maximilian","32469258"],"abstract":["PURPOSE: To report the presence of viral ribonucleic acid (RNA) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human retina in deceased patients with confirmed novel coronavirus disease 2019 (COVID-19). PATIENTS AND METHODS: Fourteen eyes of 14 deceased patients with confirmed COVID-19 disease were enucleated during autopsy. A sample of human retina was secured and fixed in RNAlater. Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) was performed to detect three different viral RNA sequences (RdRp-gene, E-gene and Orf1 gene) of SARS-CoV-2. RESULTS: In three out of 14 eyes SARS-CoV-2 viral RNA was detected in the retina of deceased COVID-19 patients. As analysis for three different sequences (RdRp-gene, E-gene and Orf1 gene) revealed positive results in RT-PCR, the existence of SARS-CoV-2 viral RNA in human retina is proven according to the standards of the World-Health-Organization. CONCLUSION: Viral RNA of SARS-CoV-2 is detectable in the retina of COVID-19 patients."],"journal":"Ocul Immunol Inflamm","authors":["Casagrande, Maria","Fitzek, Antonia","Puschel, Klaus","Aleshcheva, Ganna","Schultheiss, Heinz-Peter","Berneking, Laura","Spitzer, Martin S","Schultheiss, Maximilian"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32469258","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1080/09273948.2020.1770301","keywords":["ace-2","covid-19","rt-pcr","sars-cov-2","autopsy","retina"],"topics":["Mechanism","Diagnosis"],"weight":1,"_version_":1668420887159767040,"score":293.2951},{"pmid":32366599,"title":"SARS-CoV-2 detection in formalin-fixed paraffin-embedded tissue specimens from surgical resection of tongue squamous cell carcinoma.","text":["SARS-CoV-2 detection in formalin-fixed paraffin-embedded tissue specimens from surgical resection of tongue squamous cell carcinoma.","In the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, pathologists can be exposed to infection handling surgical specimens. Guidelines related to safety procedures in the laboratory have been released. However, there is a lack of studies performed on biopsy and surgical resection specimens. Here we report the detection of SARS-CoV-2 in formalin-fixed paraffin-embedded samples from surgical resection of tongue squamous cell carcinoma of a patient who developed COVID-19 postsurgery. RNA of SARS-CoV-2 strain was detected in the tumour and the normal submandibular gland samples using real-time PCR-based assay. No viral RNA was found in metastatic and reactive lymph nodes. We demonstrated that SARS-CoV-2 RNA can be detected in routine histopathological samples even before COVID-19 disease development. These findings may give important information on the possible sites of infection or virus reservoir, and highlight the necessity of proper handling and fixation before sample processing.","J Clin Pathol","Guerini-Rocco, Elena","Taormina, Sergio Vincenzo","Vacirca, Davide","Ranghiero, Alberto","Rappa, Alessandra","Fumagalli, Caterina","Maffini, Fausto","Rampinelli, Cristiano","Galetta, Domenico","Tagliabue, Marta","Ansarin, Mohssen","Barberis, Massimo","32366599"],"abstract":["In the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, pathologists can be exposed to infection handling surgical specimens. Guidelines related to safety procedures in the laboratory have been released. However, there is a lack of studies performed on biopsy and surgical resection specimens. Here we report the detection of SARS-CoV-2 in formalin-fixed paraffin-embedded samples from surgical resection of tongue squamous cell carcinoma of a patient who developed COVID-19 postsurgery. RNA of SARS-CoV-2 strain was detected in the tumour and the normal submandibular gland samples using real-time PCR-based assay. No viral RNA was found in metastatic and reactive lymph nodes. We demonstrated that SARS-CoV-2 RNA can be detected in routine histopathological samples even before COVID-19 disease development. These findings may give important information on the possible sites of infection or virus reservoir, and highlight the necessity of proper handling and fixation before sample processing."],"journal":"J Clin Pathol","authors":["Guerini-Rocco, Elena","Taormina, Sergio Vincenzo","Vacirca, Davide","Ranghiero, Alberto","Rappa, Alessandra","Fumagalli, Caterina","Maffini, Fausto","Rampinelli, Cristiano","Galetta, Domenico","Tagliabue, Marta","Ansarin, Mohssen","Barberis, Massimo"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32366599","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1136/jclinpath-2020-206635","keywords":["pathology, molecular","pathology, oral","viruses"],"e_drugs":["Formaldehyde","Paraffin"],"topics":["Diagnosis"],"weight":1,"_version_":1666138496183566337,"score":276.7718},{"pmid":32478289,"pmcid":"PMC7251277","title":"The origin of SARS-CoV-2 in Istanbul: Sequencing findings from the epicenter of the pandemic in Turkey.","text":["The origin of SARS-CoV-2 in Istanbul: Sequencing findings from the epicenter of the pandemic in Turkey.","OBJECTIVE: Turkey is one of the latest countries that COVID-19 disease was reported, with the first case on March 11, 2020, and since then, Istanbul became the epicenter of the pandemic in Turkey. Here, we reveal sequences of the virus isolated from three different patients with various clinical presentations. METHODS: Nasopharyngeal swab specimens of the patients were tested positive for the COVID-19 by qRT-PCR. Viral RNA extraction was performed from the same swab samples. Amplicon based libraries were prepared and sequenced using the Illumina NextSeq platform. Raw sequencing data were processed for variant calling and generating near-complete genome sequences. All three genomes were evaluated and compared with other worldwide isolates. RESULTS: The patients showed various clinics (an asymptomatic patient, patient with mild disease, and with severe pulmonary infiltration). Amplicon-based next-generation sequencing approach successfully applied to generate near-complete genomes with an average depth of 2.616. All three viral genomes carried the D614G variant (G clade according to GISAID classification) with implications for the origin of a spread first through China to Europe then to Istanbul. CONCLUSION: Here, we report the viral genomes circulating in Istanbul for the first time. Further sequencing of the virus isolates may enable us to understand variations in disease presentation and association with viral factors if there is any. In addition, the sequencing of more viral genomes will delineate the spread of disease and will guide and ease the necessary measures taken to stem the spread of the novel coronavirus.","North Clin Istanb","Karacan, Ilker","Akgun, Tugba Kizilboga","Agaoglu, N Bugra","Irvem, Arzu","Alkurt, Gizem","Yildiz, Jale","Kose, Betsi","Ozel, A Serra","Altunal, L Nilsun","Can, Nisan Denizce","Demirkol, Yasemin Kendir","Aydin, Mehtap","Dogan, Ozlem Akgun","Doganay, Levent","Doganay, Gizem Dinler","32478289"],"abstract":["OBJECTIVE: Turkey is one of the latest countries that COVID-19 disease was reported, with the first case on March 11, 2020, and since then, Istanbul became the epicenter of the pandemic in Turkey. Here, we reveal sequences of the virus isolated from three different patients with various clinical presentations. METHODS: Nasopharyngeal swab specimens of the patients were tested positive for the COVID-19 by qRT-PCR. Viral RNA extraction was performed from the same swab samples. Amplicon based libraries were prepared and sequenced using the Illumina NextSeq platform. Raw sequencing data were processed for variant calling and generating near-complete genome sequences. All three genomes were evaluated and compared with other worldwide isolates. RESULTS: The patients showed various clinics (an asymptomatic patient, patient with mild disease, and with severe pulmonary infiltration). Amplicon-based next-generation sequencing approach successfully applied to generate near-complete genomes with an average depth of 2.616. All three viral genomes carried the D614G variant (G clade according to GISAID classification) with implications for the origin of a spread first through China to Europe then to Istanbul. CONCLUSION: Here, we report the viral genomes circulating in Istanbul for the first time. Further sequencing of the virus isolates may enable us to understand variations in disease presentation and association with viral factors if there is any. In addition, the sequencing of more viral genomes will delineate the spread of disease and will guide and ease the necessary measures taken to stem the spread of the novel coronavirus."],"journal":"North Clin Istanb","authors":["Karacan, Ilker","Akgun, Tugba Kizilboga","Agaoglu, N Bugra","Irvem, Arzu","Alkurt, Gizem","Yildiz, Jale","Kose, Betsi","Ozel, A Serra","Altunal, L Nilsun","Can, Nisan Denizce","Demirkol, Yasemin Kendir","Aydin, Mehtap","Dogan, Ozlem Akgun","Doganay, Levent","Doganay, Gizem Dinler"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32478289","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.14744/nci.2020.90532","keywords":["covid-19","sars-cov-2","whole-genome sequencing"],"locations":["Turkey","Istanbul","Turkey","China","Istanbul","Istanbul","Istanbul","Turkey"],"countries":["Turkey","China"],"countries_codes":["TUR|Turkey","CHN|China"],"topics":["Mechanism"],"weight":1,"_version_":1668437835024171008,"score":245.8708}]}